Skip to main content
. 2017 Nov 27;7:16428. doi: 10.1038/s41598-017-16681-y

Figure 1.

Figure 1

Isolation of disease-associated autoantibody clones in SLE. (AC) Summary of self-reactive tests for reconstituted monoclonal antibodies. Percentages of self-reactive clones determined by anti-dsDNA and anti-CL ELISA (A), polyreactive clones to self-antigens (dsDNA, CL and insulin as a unrelated self-antigen) (healthy donors [6 donors, n = 150], SLE patients in remission [3 donors, n = 74], and SLE acute patients [5 donors, n = 199]) (B), and ANA clones in IFA (healthy donors [6 donors, n = 150], SLE patients in remission [3 donors, n = 74], SLE acute patients [6 donors, n = 239]) (C). (D and E) IFA. Hep 2 cells were stained with diluted sera (D), dilution factor = 1:160 or more for acute SLE subjects, 1:40 for healthy control), or represented monoclonal ANA clones (2 μg/ml for SLE10C6; 0.67 μg/ml for 51F1, 91E12, and 113F3; 0.2 μg/ml for 121G9 and SLE7H4), or non-ANA clone HD2A3 (2 μg/ml). Bars = 20 μm (E).